BG

Bunge Global SA

Add to Watchlist

Advanced Chart

82.520

+0.3(0.365%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

85.310

Open

82.300

VWAP

83.26

Vol

2.79M

Mkt Cap

16.51B

Low

81.950

Amount

232.58M

EV/EBITDA(TTM)

10.23

Total Shares

141.60M

21.01B

EV/OCF(TTM)

20.54

P/S(TTM)

0.22

Bunge Global SA is a global agribusiness and food company. The Company is engaged in the processing of oilseeds and the production and supply of specialty vegetable oils and fats. Its segments include Agribusiness, Refined and Specialty Oils, and Milling segments. The Agribusiness segment is principally involved in the purchase, storage, transportation, processing and sale of agricultural commodities and commodity products. The Refined and Specialty Oils segment involves the processing, production, and marketing of products derived from vegetable oils and fats, including cooking oils, shortenings, specialty ingredients, and renewable diesel feedstocks. The Milling segment involves the processing, production, and marketing of products derived primarily from wheat and corn. It serves a diverse set of industries, including animal feed and pet food, bakery, beverages, biofuels, confectionery, culinary snacks and frying, dairy, foodservice, meat, nutrition, personal care, and more.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

14.04B

+20.61%

1.699

-6.13%

29.21B

+115.68%

2.823

+32.54%

22.35B

+73.15%

1.377

-39.87%

Estimates Revision

The market is revising Upward the revenue expectations for Bunge Global SA (BG) for FY2025, with the revenue forecasts being adjusted by 0.28% over the past three months. During the same period, the stock price has changed by 2.96%.

Revenue Estimates for FY2025

Revise Upward

+0.28%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-0.39%

In Past 3 Month

Stock Price

Go Up

+2.96%

In Past 3 Month

7 Analyst Rating

7.85% Upside

Wall Street analysts forecast BG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BG is 89.00 USD with a low forecast of 74.00 USD and a high forecast of 100.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

5 Buy

2 Hold

0 Sell

Moderate Buy

7.85% Upside

Current: 82.520

Low

74.00

Averages

89.00

High

100.00

7.85% Upside

Current: 82.520

Low

74.00

Averages

89.00

High

100.00

BofA

Salvator Tiano

Buy

maintain

$90 -> $95

2025-08-01

Reason

BofA

Salvator Tiano

Price Target

$90 -> $95

2025-08-01

maintain

Buy

Reason

BofA analyst Salvator Tiano raised the firm's price target on Bunge to $95 from $90 and keeps a Buy rating on the shares. With more clarity on biofuel quotas in the U.S. and incremental moves towards biodiesel in Brazil, the near-term set-up for Bunge has improved "materially," the analyst tells investors.

Stephens

Overweight

downgrade

$90 -> $85

2025-05-08

Reason

Stephens

Price Target

$90 -> $85

2025-05-08

downgrade

Overweight

Reason

Stephens lowered the firm's price target on Bunge to $85 from $90 and keeps an Overweight rating on the shares after the company reported Q1 results. Near-term results are expected to remain challenged, but with the potential for a significant increase in the 2026 BBD RVO, board crush margins are seen being "healthy" in the back half of FY25, the analyst tells investors.

Citigroup

Thomas Palmer

Hold

Maintains

$76 → $77

2025-04-15

Reason

Citigroup

Thomas Palmer

Price Target

$76 → $77

2025-04-15

Maintains

Hold

Reason

Citi analyst Thomas Palmer raised the firm's price target on Bunge to $77 from $76 and keeps a Neutral rating on the shares. The firm sees a challenging set up into earnings for the agricultural products companies. Earnings downside is more likely than upside and the companies could lay out incrementally more cautious forward outlooks than were discussed a quarter ago, the analyst tells investors in a research note.

B of A Securities

Steve Byrne

Strong Buy

Maintains

$105 → $87

2025-02-11

Reason

B of A Securities

Steve Byrne

Price Target

$105 → $87

2025-02-11

Maintains

Strong Buy

Reason

Morgan Stanley

Vincent Andrews

Hold

Maintains

$90 → $74

2025-02-11

Reason

Morgan Stanley

Vincent Andrews

Price Target

$90 → $74

2025-02-11

Maintains

Hold

Reason

Morgan Stanley lowered the firm's price target on Bunge (BG) to $74 from $90 and keeps an Equal Weight rating on the shares. Ahead of Q3 reporting, the firm notes it outlined its view that 2025 EPS should be biased lower with supply risk outweighing upside potential from demand and, exiting Q4 reporting, this path of least resistance has "proven out to be lower and more 2H-weighted than previously expected," says the analyst, who is reducing estimates and price targets for Archer Daniels (ADM) and Bunge.

Barclays

Benjamin Theurer

Hold

Maintains

$95 → $85

2025-02-06

Reason

Barclays

Benjamin Theurer

Price Target

$95 → $85

2025-02-06

Maintains

Hold

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Bunge Global SA (BG.N) is 10.25, compared to its 5-year average forward P/E of 9.58. For a more detailed relative valuation and DCF analysis to assess Bunge Global SA 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

9.58

Current PE

10.25

Overvalued PE

11.45

Undervalued PE

7.71

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

7.59

Current EV/EBITDA

7.91

Overvalued EV/EBITDA

8.91

Undervalued EV/EBITDA

6.27

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

0.22

Current PS

0.22

Overvalued PS

0.25

Undervalued PS

0.19